Hepatitis A vaccine

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:approvedBy gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
1992
gptkbp:ATCCode gptkb:J07BC02
gptkbp:boosterRecommended not routinely recommended
gptkbp:brand gptkb:Vaqta
gptkb:Avaxim
gptkb:Epaxal
gptkb:Havrix
gptkbp:broadcastOn two doses
gptkbp:category vaccine
gptkbp:combinationProduct gptkb:Twinrix
gptkbp:combines gptkb:Hepatitis_B_vaccine
gptkbp:contains inactivated Hepatitis A virus
gptkbp:contraindication severe allergic reaction to previous dose
gptkbp:countryOfOperation gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
gptkbp:developedBy gptkb:Sanofi_Pasteur
gptkb:Merck_&_Co.
gptkb:SmithKline_Beecham
gptkb:Crucell
gptkbp:duration at least 20 years
https://www.w3.org/2000/01/rdf-schema#label Hepatitis A vaccine
gptkbp:immunityOnset 2 to 4 weeks after first dose
gptkbp:indication adults
children
gptkbp:intervalBetweenDoses 6 to 12 months
gptkbp:legalStatus prescription only
gptkbp:pregnancyCategory C (US)
gptkbp:prevention gptkb:Hepatitis_A
gptkbp:recommendation gptkb:men_who_have_sex_with_men
travelers to endemic areas
people with chronic liver disease
people who use illicit drugs
gptkbp:routeOfAdministration intramuscular injection
gptkbp:sideEffect fatigue
headache
loss of appetite
soreness at injection site
gptkbp:storage 2–8°C
gptkbp:targetAudience adults at risk
all children at age 1 year
gptkbp:WHOModelListOfEssentialMedicines included
gptkbp:bfsParent gptkb:Hepatitis_B_Vaccine
gptkb:Hepatitis_A
gptkbp:bfsLayer 6